![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 49, 47235-47241, December 6, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Laboratory of Cellular Oncology, Center for Cancer
Research, NCI, National Institutes of Health,
Bethesda, Maryland 20892
The effectors of monomeric GTP-binding proteins
can influence interactions with GTPase-activating proteins (GAPs) in
two ways. In one case, effector and GAP binding to the GTP-binding
protein is mutually exclusive. In another case, the GTP-binding
protein bound to an effector is the substrate for the GTPase-activating protein. Here predictions for these two mechanisms were tested for the
Arf1 effector GGA and ASAP family Arf GAPs. GGA inhibited Arf GAP
activity of ASAP1, AGAP1, ARAP1, and Arf GAP1 and inhibited binding of
Arf1·GTP
Arf1 Dissociates from the Clathrin Adaptor GGA Prior to Being
Inactivated by Arf GTPase-activating Proteins*
S to AGAP1 with Ki values correlating with the Kd for the GGA·Arf1 complex. ASAP1
blocked Arf1·GTP
S binding to GGA with a Ki
similar to the Kd for the ASAP·Arf1·GTP
S
complex. No interaction of GGA with ASAP1 was detected. Consistent with
GGA sequestering Arf from GAPs, overexpression of GGA slowed the rate
of Arf dissociation from the Golgi apparatus following treatment with
brefeldin A. Mutational analysis revealed the amino-terminal
-helix
and switch I of Arf1 contributed to interaction with both GGA and GAPs.
These data exclude the mechanism previously documented for Arf
GAP1/coatomer in which Arf1 is inactivated in a tripartite complex.
Instead, termination of Arf1 signals mediated through GGA require that Arf1·GTP dissociates from GGA prior to interaction with GAP and consequent hydrolysis of GTP.
*
This work was supported by the Center for Cancer
Research and NCI, National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Laboratory of Cellular
Oncology, Center for Cancer Research, NCI, Bldg. 37, Rm. 6032, National
Institutes of Health, Bethesda, MD 20892. Tel.: 301-496-3788; Fax:
301-480-1260; E-mail: randazzo@helix.nih.gov.
This article has been cited by other articles:
![]() |
J. B. Bowzard, D. Cheng, J. Peng, and R. A. Kahn ELMOD2 Is an Arl2 GTPase-activating Protein That Also Acts on Arfs J. Biol. Chem., June 15, 2007; 282(24): 17568 - 17580. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hu, Z. Liu, and K. Ye Phosphoinositol lipids bind to phosphatidylinositol 3 (PI3)-kinase enhancer GTPase and mediate its stimulatory effect on PI3-kinase and Akt signalings PNAS, November 15, 2005; 102(46): 16853 - 16858. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Liu, C.-F. Huang, K.-B. Huang, and F.-J. S. Lee Role for Gcs1p in Regulation of Arl1p at Trans-Golgi Compartments Mol. Biol. Cell, September 1, 2005; 16(9): 4024 - 4033. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suer, S. Misra, L. F. Saidi, and J. H. Hurley Structure of the GAT domain of human GGA1: A syntaxin amino-terminal domain fold in an endosomal trafficking adaptor PNAS, April 15, 2003; 100(8): 4451 - 4456. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |